Research and Markets has announced the “Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic Markets 2016-2020” report. A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. GRAIL, a new company ...
Read More »Liquid Biopsy Cancer Diagnostics Market – Anticipated to Grow Aggressively at 44% CAGR
Liquid biopsy primarily focuses on the detection, isolation and characterization of biomarkers from circulating tumor cells (CTCs), circulating tumor DNA (ctDNA) or exosomes present in biological fluids, which can be collected in a single blood draw. Primarily driven by liquid ...
Read More »